What to know about AMX0035
from Endpoints Hosted by ALS TDI
In this episode of the Endpoints, Dr. Steve Perrin, CSO at the ALS Therapy Development Institute, sits down to talk about AMX0035, a drug consisting of a combination of two small molecule compounds: sodium phenylbutyrate and tauroursodeoxycholic acid (TUDCA). Amylyx, the sponsor of AMX0035, recently completed enrollment of a 132 participant phase 2 trial. To learn more about the ALS Therapy Development Institute and our mission to end ALS, click here. Support the show: https://www.als.net/donate/
Embed this episode
No transcript yet.
Similar podcasts
Endpoint Pulse
ManageEngine Endpoint Central
Welcome to Endpoint Pulse, the go-to podcast for all things cybersecurity and endpoint management. From interviews with our customers/MVPs to exploring the next big thing in endpoint management and security, join us as we dive deep into the stories, trends, and best practices, occasionally laced with some humor. So, whether you're a tech enthusiast, a cybersecurity fanatic, a system administrator, or someone just curious about how endpoints are managed behind the scenes, this podcast is for you.https://www.manageengine.com/products/desktop-central/endpoint-pulse/
Jamf After Dark
Jamf
Device management is complex. Security threats are constant. Apple ecosystems are evolving fast. Who's managing these challenges? What does it actually take? And most importantly, how do you stay ahead? Welcome to Jamf After Dark, where IT leaders, security professionals and Apple experts tackle the real issues facing organisations today. Join our hosts as they uncover what works, what doesn't, and how to build technology strategies that actually stick. Hear honest conversations about managing devices at scale, securing endpoints, protecting data, and supporting hybrid workforces. New Jamf features and capabilities. Real stories from IT teams solving actual problems. For IT Admins, Mac admins,directors, security specialists, educators and Apple advocates.
IGEL Weekly
XenTegra
Welcome to IGEL Weekly, the podcast that explores the future of endpoint management and cloud workspaces. Hosted by XenTegra, this show dives deep into IGEL’s next-generation edge OS solutions. Discover how IGEL delivers extreme hardware cost savings, reduced operating expenses, and a more secure, streamlined platform for endpoint management across nearly any x86 device. Each week, we’ll unpack the latest industry trends, IGEL updates, and actionable insights to help you optimize your IT environment. Whether you're an IT leader, administrator, or simply curious about the future of endpoints, IGEL Weekly is your go-to source for staying ahead in the rapidly evolving world of digital workspaces. Tune in to gain knowledge, stay informed, and transform the way you manage your endpoints.
IGEL Weekly
XenTegra
Welcome to IGEL Weekly, the podcast that explores the future of endpoint management and cloud workspaces. Hosted by XenTegra, this show dives deep into IGEL’s next-generation edge OS solutions. Discover how IGEL delivers extreme hardware cost savings, reduced operating expenses, and a more secure, streamlined platform for endpoint management across nearly any x86 device. Each week, we’ll unpack the latest industry trends, IGEL updates, and actionable insights to help you optimize your IT environment. Whether you're an IT leader, administrator, or simply curious about the future of endpoints, IGEL Weekly is your go-to source for staying ahead in the rapidly evolving world of digital workspaces. Tune in to gain knowledge, stay informed, and transform the way you manage your endpoints.
Frequently asked questions
How long is this episode of Endpoints?
This episode is 8 minutes long.
When was this Endpoints episode published?
This episode was published on October 31, 2019.
Can I download this Endpoints episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.